English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The hetero-tetrameric voltage-gated potassium channel K v 7.2/K v 7.3, which is encoded by  KCNQ2  and  KCNQ3 , plays an important role in limiting network excitability in the neonatal brain. K v 7.2/K v 7.3 dysfunction resulting from  KCNQ2  mutations predominantly causes self-limited or benign epilepsy in neonates, but also causes early onset epileptic encephalopathy. Retigabine (RTG), a K v 7.2/ K v 7.3-channel opener, seems to be a rational antiepileptic drug for epilepsies caused by  KCNQ2  mutations. We therefore evaluated the effects of RTG on seizures in two strains of knock-in mice harboring different  Kcnq2  mutations, in comparison to the effects of phenobarbital (PB), which is the first-line antiepileptic drug for seizures in neonates. The subjects were heterozygous knock-in mice ( Kcnq2  Y284C/+  and  Kcnq2  A306T/+ ) bearing the Y284C or A306T  Kcnq2  mutation, respectively, and their wild-type (WT) littermates, at 63–100 days of age. Seizures induced by intraperitoneal injection of kainic acid (KA, 12mg/kg) were recorded using a video-electroencephalography (EEG) monitoring system. Effects of RTG on KA-induced seizures of both strains of knock-in mice were assessed using seizure scores from a modified Racine’s scale and compared with those of PB. The number and total duration of spike bursts on EEG and behaviors monitored by video recording were also used to evaluate the effects of RTG and PB. Both  Kcnq2  Y284C/+  and  Kcnq2  A306T/+  mice showed significantly more KA-induced seizures than WT mice. RTG significantly attenuated KA-induced seizure activities in both  Kcnq2  Y284C/+  and  Kcnq2  A306T/+  mice, and more markedly than PB. This is the first reported evidence of RTG ameliorating KA-induced seizures in knock-in mice bearing mutations of  Kcnq2 , with more marked effects than those observed with PB. RTG or other K v 7.2-channel openers may be considered as first-line antiepileptic treatments for epilepsies resulting from  KCNQ2  mutations.

Retigabine, a Kv7.2/Kv7.3-Channel Opener, Attenuates Drug-Induced Seizures in Knock-In Mice Harboring Kcnq2 Mutations